Looks like SENS has touched $2.42 area for the second time and could be the signal for a possible bullish reversal. If it does reverse just know this stock likes to lose its gains pretty quickly so don't be greedy. I believe this is a perfect entry to go LONG. We are waiting on FDA approval that will probably gap us up back to the $5 range.
It looks like wave 2 has completed for SENS. They had a conference today march 9th about some things that were already known to us, but they made some things more clear. Quick summary of this conference: - Accuracy of the current device is best in class with a MARD of 8.5% - Medicare National Coverage as of Jan 1, 2021: - Avg "Supply Cost" (I assume this is for...
Nice rejection from the green cloud base . Strong resistance at 3.73 and 4.17 if can break out 4.17 then possible targeting ATH at 5.5 then 6.97 and 7.83 but it may take some time .. STOP AT 2.5
I see a wedge in a downtrend. However, the momentum suggests there could be a reversal. Breakout on Monday?
Looks like a clear flag forming at a strong support line. Let me know what you think, this is my first shared chart. Clearly not financial advise.
ATH was at 5.3 . Strong resistance at 4.25 . above it will see ATH then above it goals will be 6.2 - 7.2 - 8.3 which almost double current price. Stop at 2.8 for long view! . Worth to say, this name jumped from 0.4 to 4 during A month!! which means its high risky trade too.
After first money of first PUMP is out. Second one firing. Good company essentials and new product in the pipeline with Social security insurance coverage. Waiting to get confirmation about their financials tomorrow after market closing. Ready for next similar angle up before end of March already.
Buddy and I found these potential trends in SENS. It's lower due to the recents news around the FDA approval. But I could see both potential trends happening based on the past. Who knows. This stock is definitely on my watchlist to test it out depending on what further info comes out.
Wave 3 correction to Wave 4. Hit Fib 0.61 retracement level. Could it be the end of Wave 4? Might see price lingering within $3.29-2.99. Until it bounces off $3.29 and shows bullish sign, currently a downward momentum. Stop Loss $2.4. Profit $4.2. $4.2 is key resistance level. Once breakout then Fib Ext 61.8% at $5.25.
The company and its goals are still the same. I cannot explain why but a movement before a earnings report is often negative, and raises shortly before the earnings report is reviled. According to the NASDAQ holders list, some of the large like the rest of the market are selling there stocks but nothing substantial, and the majority of them are still holding. I'm...
SENS is a medical tech company focused on the design and development of glucose monitoring products designed to help people with diabetes. Pricetarget wave 2 correction: $3.00 Pricetarget wave 3: $12-24. The pricetarget of wave 3 will likely be driven by the US FDA approval coming march 2021. Hype will most likely drive the early stages of wave 3. Hopefully...
SENS looks like its going to continue bullish this week. MACD reversal, oversold on RSI, still gaining volume.
Personally analyze that it will continue to go up, if not, it will go sideways and move up in the next 2-3 days..
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics...